It has recently been reported that a genetic polymorphism in exon 2 of the
cathepsin D gene conferred increased risk for development of Alzheimer's di
sease (AD). Because of the potential importance of this report we tested th
is association in a clinically well-defined group of AD patients and age an
d sex matched control subjects from the relatively genetically homogeneous
Northern Ireland population. This study failed to confirm the reported asso
ciation between the cathepsin D exon 2 polymorphism and AD. We conclude tha
t if an association exists between this polymorphism and AD it is likely to
be small. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.